NCT02949115

Brief Summary

Aside from aging, numerous factors increase the risk for developing cardiovascular disease (CVD) including diet and nutrition. High-fat meal consumption induces postprandial vascular endothelial dysfunction and other cardiometabolic disturbances (e.g. dyslipidemia and hyperglycemia) in normal weight individuals and is exacerbated in overweight/obese individuals. These postprandial responses are likely largely due to activation of pro-inflammatory and pro-oxidant pathways. Given that much of the day is spent in the postprandial state, this may further impair cardiovascular health in aging overweight/obese individuals. Interventions that attenuate these responses are needed. Red beetroot (Beta vulgaris L.) is an excellent source of bioactive compounds including nitrate, flavonoids, phenolic acids, betalains, carotenoids, and ascorbic acid. These bioactive compounds and their metabolites have been shown to have antioxidative, anti-inflammatory, and cardiovascular-protective effects. These effects, particularly the cardiovascular-protective effects, have been primarily attributed to its high content of nitrate since it is converted to nitric oxide independent of the vascular endothelium via the enterosalivary nitrate-nitrite-nitric oxide pathway. However, red beetroot juice contains a number of other potentially beneficial bioactive compounds and few studies have aimed to determine whether these compounds work independently, additively, or synergistically in exerting these effects. Given the findings of previously conducted research in the broad area of red beetroot juice consumption and human health, it can be suggested that: 1) acute red beetroot juice consumption may prevent or attenuate the adverse postprandial responses to consuming a high-fat meal in individuals with exaggerated responses; and 2) chronic consumption of red beetroot may improve underlying factors contributing to these exaggerated responses. Accordingly, this project aims to: 1) investigate the efficacy of acute and chronic whole red beetroot juice consumption compared with its bioactive components in attenuating postprandial vascular endothelial dysfunction and adverse cardiometabolic responses to a high-fat meal; and 2) to gain insight into the underlying mechanisms responsible.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Nov 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 31, 2016

Completed
1 day until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
Last Updated

November 13, 2018

Status Verified

November 1, 2018

Enrollment Period

1.7 years

First QC Date

October 26, 2016

Last Update Submit

November 8, 2018

Conditions

Keywords

Red beetrootDietary NitratePolyphenolsEndothelial FunctionHigh-Fat MealOverweightObesityAgingCardiometabolic

Outcome Measures

Primary Outcomes (1)

  • Vascular endothelial function

    Vascular endothelial function will be assessed using reactive hyperemia index (EndoPAT) 0 and 4 hours post-meal consumption.

    0 and 4 hours post-meal consumption at baseline and 1 month for each treatment period.

Secondary Outcomes (8)

  • Blood glucose, insulin, and indices of insulin sensitivity and resistance

    0 and 1, 2, and 4 hours post-meal consumption at baseline and 1 month for each treatment period.

  • Blood triglycerides

    0 and 1, 2, and 4 hours post-meal consumption at baseline and 1 month for each treatment period.

  • Blood pressure

    0 and 1, 2, and 4 hours post-meal consumption at baseline and 1 month for each treatment period

  • Heart rate

    0 and 1, 2, and 4 hours post-meal consumption at baseline and 1 month for each treatment period.

  • Arterial stiffness

    Pre-meal consumption at baseline and 1 month for each treatment period.

  • +3 more secondary outcomes

Other Outcomes (3)

  • Blood polyphenols and polyphenol metabolites

    0, 1, 2 and 4 hours post-meal consumption at baseline and 1 month for each treatment period.

  • Urinary polyphenols and polyphenol metabolites

    0 and 24 hours post-meal consumption at baseline and 1 month for each treatment period.

  • Oral and gut microbiome

    Pre-meal consumption at baseline and 1 month for each treatment period.

Study Arms (4)

70 mL red beetroot juice

EXPERIMENTAL

70 mL red beetroot juice naturally containing 300 mg nitrate.

Dietary Supplement: 70 mL red beetroot juice

70 mL placebo drink plus potassium nitrate

ACTIVE COMPARATOR

70 mL calorie-matched placebo control drink containing 489 mg potassium nitrate to deliver 300 mg nitrate.

Dietary Supplement: 70 mL placebo drink plus potassium nitrate

70 mL red beetroot juice without nitrate

ACTIVE COMPARATOR

70 mL red beetroot juice per day without nitrate.

Dietary Supplement: 70 mL red beetroot juice without nitrate

70 mL placebo drink

PLACEBO COMPARATOR

70 mL calorie-matched placebo control drink devoid of nitrate, vitamins, minerals, and polyphenols.

Dietary Supplement: 70 mL placebo drink

Interventions

70 mL red beetroot juiceDIETARY_SUPPLEMENT

1x daily intake of 70 mL red beetroot juice

70 mL red beetroot juice

1x daily intake of 70 mL red beetroot juice without nitrate

70 mL red beetroot juice without nitrate

1x daily intake of 70 mL placebo control drink plus 489 mg potassium nitrate (300 mg nitrate)

70 mL placebo drink plus potassium nitrate
70 mL placebo drinkDIETARY_SUPPLEMENT

1x daily intake of 70 mL placebo control drink

70 mL placebo drink

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Postmenopausal women and men
  • BMI between 25 and 40 kg/m2

You may not qualify if:

  • Hypertension, cardiovascular disease, diabetes, cancer, or kidney, liver, or pancreatic disease
  • Individuals taking gastroesophageal reflux, antihypertensive, hypoglycemic, lipid-lowering, hormone replacement, erectile dysfunction medications or nitrates
  • Participating in a weight loss program or actively trying to lose weight
  • Smokers
  • Heavy drinkers (\> 3 drinks on any given occasion and/or \> 7 drinks/week for women, or \> 4 drinks on any given occasion and/or \> 14 drinks/week for men)
  • Allergy to meals/treatments
  • Consuming \> 2 servings red beetroot or beetroot juice/wk

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Food Science and Human Nutrition, Colorado State University

Fort Collins, Colorado, 80523-1571, United States

Location

Related Publications (1)

  • Litwin NS, Van Ark HJ, Hartley SC, Michell KA, Vazquez AR, Fischer EK, Melby CL, Weir TL, Wei Y, Rao S, Hildreth KL, Seals DR, Pagliassotti MJ, Johnson SA. Impact of Red Beetroot Juice on Vascular Endothelial Function and Cardiometabolic Responses to a High-Fat Meal in Middle-Aged/Older Adults with Overweight and Obesity: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. Curr Dev Nutr. 2019 Oct 17;3(11):nzz113. doi: 10.1093/cdn/nzz113. eCollection 2019 Nov.

MeSH Terms

Conditions

OverweightObesity

Interventions

Nitratespotassium nitrate

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnionsIonsElectrolytesInorganic ChemicalsNitric AcidNitrogen CompoundsOrganic Chemicals

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 26, 2016

First Posted

October 31, 2016

Study Start

November 1, 2016

Primary Completion

August 1, 2018

Study Completion

June 1, 2019

Last Updated

November 13, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share

Locations